🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A terrific nurse is recognized for his tremendous care!!!

PS - actually read the paper (I know, crazy). No impact of CMV treatment or CMV EOD on mortality. So causal or a more subtle marker of immune deficiency? Paul Sax

Congratulations Cecilia - critical faculty member in ID Division and key investigator for the IGHID

Critically important UNC Division of Infectious Diseases Institute for Global Health & Infectious Diseases

Have to agree with Jose R Arribas though more data to come with DTG/DRVboosted. Two very high barrier agents. LEN and CAB both are not in that category. CROI will be great this year-go if you can

Gift wrapped "cure package" for hard to reach (wait no - HARDLY reached) patients. Another Infectious Disease service with incredible down stream value to the patient, healthcare system and public health (but no wRVUs)

Yesterday in clinic we saw our one of our older patients living with HIV for 30 + years who just had their first great, great grandchild. Seriously, who would have dreamed that up 30 years ago.

Amen! Our downstream VALUE to patients, health care systems and public health is unrecognized or unappreciated and therefore uncompensated. What "wRVU" is assigned to curing HCV (see last tweet). atCVDH(if heaven has twitter) would likely have advice.pnhp.org/news/i-was-doi…

Potentially the next step in the evolution of #HIV treatment: Gilead Sciences' lenacapavir (Sunlenca) + 2 broadly neutralizing antibodies (teropavimab & zinlirvimab) maintained viral suppression for 6 months, Joseph Eron of UNC-Chapel Hill reported at #CROI2023 poz.com/article/sunlen…

National guidelines may have played a role in #equitable access to new therapy. #racial #disparities #HIV #ART Check out Lauren Zalla’s work guided by Ada Adimora and Joseph Eron... The❓now is how ➡️unc.live/3JjgFvr

Critically important paper for HIV providers as MPox potentially becomes a uncommon endemic infection in people who have risk. Also vaccinate people with risk! pubmed.ncbi.nlm.nih.gov/36828001/

Infectious Diseases and EIS great combination.

Join Joseph Eron and Princy N. Kumar, MD on 4/11 in DC for 'CROI 2023 Update: What Did We Learn?'. Earn 2.50 AMA, ANCC, and ACPE credits. Dinner provided by CCO. Register for free: bit.ly/3LZMjQt

Looking forward to being in-person!!

Looking forward to the launch of this innovative training program UNC Division of Infectious Diseases . Applicants for combined ID/EIS training need to apply separately to EIS and ID programs. Apply now for EIS. Application period open through June 5, 2023. Joe Tucker, MD David van Duin @DavidAlainWohl

Large NIH study, Led by Steve Grinspoon and Pam Douglas, in partnership with ACTG, demonstrates that statin therapy in low and mod CVD-risk people with HIV decreases CVD outcomes. ACTG Network niaid.nih.gov/news-events/da…

Thrilled to be a part of this ACTG Network #COVID19 UW Positive Research Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19 | Annals of Internal Medicine acpjournals.org/doi/10.7326/M2…

Solar panels in Malawi to support clinical and translational research and our mother (Earth).

Mike Cohen opening the HPTN meeting. ⁦HPTN⁩ ⁦Institute for Global Health & Infectious Diseases⁩

Terrific! Congratulations to the authors including David van Duin UNC Division of Infectious Diseases Institute for Global Health & Infectious Diseases